Recon: Supreme Court rebuffs Amarin, Abbvie in separate rulings; Moderna to ramp up vaccine production

• Supreme Court rebuffs insurers on Obamacare reimbursements (Reuters)
• Supreme Court denies Amarin's bid to revive Vascepa drug patents (Reuters)
• Supreme Court rebuffs AbbVie appeal in patent fight involving AndroGel drug (Reuters) (Law360)
• Moderna plans to expand COVID-19 vaccine production (Reuters) (WSJ)
• HHS backs down in legal fight over drug discount program with AstraZeneca, Eli Lilly, Novo and Sanofi (Endpoints) (Law360)
• Gilead's remdesivir reduces COVID-19 mortality risk- data (Reuters)
• 8 key clinical trials to watch for the rest of 2021 (BioPharmaDive)

• S.Africa's Ramaphosa accuses Big Pharma of 'selfish, unjust' vaccine policy (Reuters)
• WTO head says South Africa, Senegal, Rwanda and Nigeria considered as vaccine production hubs (Reuters)
• Study confirms GSK-Vir antibody drug reduces hospitalization, death in COVID-19 patients (Reuters)
• GSK to boost spending power of pharma business post break-up (Reuters)
• GSK faces struggle to convince investors as activist Elliott lurks (FT)
• Vaccitech chief confident of beating mRNA in cancer treatment (FT)
• India in talks to find 'middle ground' with Pfizer, others for vaccine imports -govt official (Reuters)
• NZ regulator approves Pfizer vaccine for 12-15 year olds (Reuters)
• S.Korea's SK bioscience to invest $132 mln to boost vaccine production (Reuters)
• Ebola outbreak in Guinea is over: WHO (The Hill)

• With Vaccination Goal in Doubt, Biden Warns of Variant’s Threat (NYTimes)
• European Union loses bid for faster deliveries of AstraZeneca Covid-19 vaccine (STAT)
• Fight Over Covid’s Origins Renews Debate on Risks of Lab Work (NYTimesv
• )
• Cuba’s homegrown Covid vaccine shows promise (FT)
• Models predict U.S. coronavirus infections could surge this fall if vaccination rates lag, former FDA chief says (Washington Post)
• Philippines seals biggest COVID-19 vaccine order yet, for 40 mln Pfizer doses (Reuters)
• Not done yet: Roche nets new FDA COVID-19 authorization for point-of-care PCR screening test (Fierce)

• Medical journal argues a drug maker’s libel suit is really a public relations campaign to chill research (STAT)
• FDA’s Budget: Advancing the Goal of Ending the Opioid Crisis (FDA)
• A California law that bans drug coupons failed to increase generic use (STAT)
• EU approves Onureg for patients with acute myeloid leukemia (Pharmafile)
• EC approves Sanofi’s Aubagio for paediatric MS patients (PharmaTimes)
• Japan OKs 2021 Fiscal Policy Blueprint, Vows Transparency in Drug Pricing (PharmaJapan)
• LAG-3 continues generating heavy buzz as Australia's Immutep locks down new funds (Endpoints)
• Allogene, Overland woo an experienced hand from WuXi to steer their allogeneic CAR-T JV (Endpoints)
• Roche's Alzheimer's antibody lowers biomarkers in inherited form of disease, though impact on symptoms is unclear (Fierce)
• Orphan drug specialist Horizon looks to double down on its gout expertise with acquired rights to Arrowhead's RNAi med (Endpoints)
• Activist investor Elliott in talks with other GlaxoSmithKline investors about replacing Emma Walmsley, spinning off vaccine business — report (Endpoints)
• Novartis burnishes Zolgensma data in presymptomatic patients as Roche's Evrysdi continues eating away at the SMA pie (Endpoints)
• Tarsus nabs key data in hunt to repurpose dog drug as cure for eye parasite (Endpoints)
• Cadila, Bayer extend JV partnership for three years (Economic Times)
• Alkem gets two observations from USFDA for St Louis-based formulation plant (Economic Times)

• Expert Panel Review Likely For Just 10% To 20% Of Files Submitted (MedtechInsight)
• NeuraLace ties up FDA clearance for chronic pain-relieving nerve stimulation device (Fierce)
• New Treatment From Shockwave Medical For Clogged Arteries Gets CMS Pass-Through Payment (MedtechInsight)
• Amazon Halo's AI-powered body fat calculator on par with lab-quality devices, study finds (Fierce)

• Democrats seek new ways to expand Medicaid in holdout states (The Hill)
• Biden nominates HHS official targeted by Trump (The Hill)
• Bard Hit With $3M Verdict In Vein Filter Suit (Law360)
• GSK Gets Top Court Assist In MDL Victory 'Roadmap' (Law360)
• J&J Accused Of Seeking 'Secrecy' In Fired Exec's Bias Suit (Law360)
• Can – or Should – State Tort Law Force Defendants To Prevent Off-Label Use? (Drug & Device Law)